The U.S. House Energy Subcommittee has scheduled hearings in early 2026 to examine regulatory barriers to deploying small modular reactors (SMRs), following four executive orders issued last May. Those orders call for three experimental reactors operational by July 4, 2026; multiple SMRs deployed by the end of 2027; and at least one nuclear reactor on a military base by 2028. Lawmakers plan to discuss streamlined licensing, targeted rulemaking and potential financial incentives to accelerate deployment, signaling strong federal backing for NuScale Power’s core technology.

NuScale Power shares have risen more than 15.6% over the past two trading days, lifting market capitalization to approximately $4.6 billion. Average daily trading volume stands near 24 million shares, with recent volume spikes above 1.7 million on surge days. Investors have seized on the prospect of accelerated SMR rollouts, driving the stock higher even as the company remains unprofitable. Market participants note that a 64.95% gross margin on early component sales underlines NuScale’s manufacturing economics, but overall cash burn remains elevated.

Despite the bullish policy environment, most analysts surveyed by S&P Global Market Intelligence forecast no positive free cash flow before 2030. Industry insiders caution that first-of-a-kind SMR units will likely not enter commercial service until after 2030, delaying revenue streams and pushing break-even well into the next decade. Given these timelines, some observers recommend that risk-averse investors defer new positions until clearer project milestones are achieved, particularly final investment decisions around NuScale’s planned 2026–2027 deployments.